Christopher Snowdon: the truth about Ozempic, obesity & the NHS
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to basket failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from Wish List failed.
Please try again later
Follow podcast failed
Unfollow podcast failed
Christopher Snowdon: the truth about Ozempic, obesity & the NHS
-
Narrated by:
-
By:
About this listen
Lifestyle economist Christopher Snowdon joins Michael Simmons to explore how weight-loss drugs like Ozempic could reshape health, policy and the economy. From the WHO’s call for mass production to flawed obesity cost estimates, failing ‘nanny state’ interventions and the future of food companies, Snowden argues that these drugs are a genuine game-changer — and warns that much of current public health thinking is fast becoming obsolete.
Become a Spectator subscriber today to access this podcast without adverts. Go to spectator.co.uk/adfree to find out more.
For more Spectator podcasts, go to spectator.co.uk/podcasts
Contact us: podcast@spectator.co.uk
Hosted on Acast. See acast.com/privacy for more information.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.